REMSleep Holdings, Inc. (RMSL)
OTCMKTS
· Delayed Price · Currency is USD
0.0100
+0.0008 (8.70%)
Apr 25, 2025, 3:43 PM EDT
REMSleep Holdings Revenue
In the year 2024, REMSleep Holdings had annual revenue of $117.19K, down -42.48%. REMSleep Holdings had revenue of $-5.55K in the quarter ending December 31, 2024, a decrease of -174.44%.
Revenue
117.19K
Revenue Growth
-42.48%
P/S Ratio
130.02
Revenue / Employee
58.59K
Employees
2
Market Cap
15.24M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.76B |
| Veradigm | 588.02M |
| Glass House Brands | 200.90M |
| Elite Pharmaceuticals | 70.00M |
| Northwest Biotherapeutics | 1.38M |
| BioStem Technologies | 301.83M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 43.26M |
REMSleep Holdings News
- 5 months ago - REMSleep Holdings, Inc. Shareholder Update - GlobeNewsWire
- 8 months ago - REMSleep Patent Application Has Been Allowed by the United States Patent and Trademark Office - GlobeNewsWire
- 1 year ago - REMSleep Holdings Patent Status - GlobeNewsWire
- 1 year ago - REMSleep Holdings Shareholder Update - GlobeNewsWire
- 3 years ago - RemSleep Holdings Inc. Engages New Senior Director for Regulatory Compliance and New Regulatory Testing Company - GlobeNewsWire
- 3 years ago - RemSleep Holdings Inc. Announces 510(k) Submission for DeltaWave - GlobeNewsWire
- 3 years ago - Condensation Testing Per ISO 18562-4:2017 - GlobeNewsWire
- 3 years ago - REMSleep Announces Condensation Testing per ISO 18562-4 :2017 - GlobeNewsWire